…
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. In addition, it offers patient monitoring systems; anaesthesia machines; medical ventilators and lung monitoring; neonatal incubators and thermoregulation; phototherapy lights and bilirubinometers; surgical and examination lights; medical pendants and infrastructure design; medical gas pipeline system in hospitals; and hospital consumables and accessories, as well as hospital planning and design services. Further, the company offers alcohol and drug testing; diving equipment; fixed gas detectors; hazmat suits; portable gas detection; head and eye protection; rescue and escape; respiratory protection; safety-training systems; thermal imaging cameras; and workshop solution and breathing gas supply, as well as provides various training and services. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | - | - | 360.17M | 49.53M | 51.65M |
| Net income | - | - | 188.59M | 24.93M | 25.68M |
| Selling general administrative | - | - | 841.65M | 771.46M | 748.48M |
| Gross profit | - | - | 1608.89M | 1188.42M | 1108.05M |
| Ebit | -90.25M | 272.34M | 399.31M | 78.87M | 60.76M |
| Operating income | - | - | 403.72M | 71.65M | 65.83M |
| Other operating expenses | 3.74M | 1.87M | 8.08M | 2.13M | 2.10M |
| Interest expense | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Tax provision | - | - | 110.28M | 15.74M | 16.75M |
| Interest income | - | - | 38.26M | 14.99M | 7.92M |
| Income tax expense | -38.77M | 82.38M | 110.28M | 15.74M | 16.75M |
| Total revenue | - | - | 3406.28M | 2780.82M | 2595.01M |
| Cost of revenue | - | - | 1797.38M | 1592.40M | 1486.96M |
| Net income applicable to common shares | -64.56M | 134.32M | 188.59M | 24.93M | 25.68M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | - | - | 3305.99M | 2570.91M | 2410.23M |
| Intangible assets | - | - | 23.00M | 24.69M | 27.06M |
| Other current assets | 25.80M | 17.14M | 30.46M | 18.40M | 18.69M |
| Total liab | - | - | 2273.09M | 1496.11M | 1330.99M |
| Total stockholder equity | - | - | 1032.90M | 1074.80M | 1079.23M |
| Other current liab | 596.17M | 398.18M | 635.73M | 271.75M | 349.71M |
| Common stock | 48.03M | 48.03M | 48.03M | 45.47M | 45.47M |
| Retained earnings | 969.30M | 924.97M | 716.47M | 779.16M | 790.04M |
| Other liab | 326.25M | 712.44M | 879.26M | 520.50M | 446.59M |
| Good will | - | - | 307.96M | 309.29M | 308.96M |
| Other assets | 307.02M | 303.95M | 317.16M | 234.48M | 194.03M |
| Cash | - | - | 492.23M | 188.44M | 175.21M |
| Total current liabilities | 1218.52M | 934.91M | 1152.92M | 746.59M | 723.33M |
| Short long term debt total | - | - | 238.84M | 199.86M | 132.44M |
| Other stockholder equity | -6.32M | -20.12M | -38.63M | 16.15M | 9.70M |
| Property plant equipment | 517.98M | 516.25M | 503.74M | 488.22M | 398.25M |
| Total current assets | 1902.63M | 1991.70M | 2147.03M | 1509.48M | 1476.50M |
| Net tangible assets | 970.34M | 907.04M | 705.34M | 744.86M | 744.57M |
| Short term investments | - | - | 154.76M | 9.08M | 6.04M |
| Net receivables | 834.27M | 749.39M | 833.19M | 784.93M | 791.68M |
| Long term debt | - | - | 157.81M | 118.57M | 125.08M |
| Inventory | 696.98M | 616.76M | 620.82M | 485.16M | 459.19M |
| Accounts payable | 285.61M | 223.98M | 234.62M | 205.11M | 201.44M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Investments | - | - | 122.06M | 3.04M | -149.68M |
| Change to liabilities | - | - | 66.27M | -15.84M | 29.71M |
| Total cashflows from investing activities | - | - | 36.83M | -109.92M | -263.08M |
| Net borrowings | - | - | -60.98M | -66.19M | 57.73M |
| Total cash from financing activities | - | - | -29.38M | -334.64M | 114.25M |
| Change to operating activities | - | - | -60.41M | -83.58M | 185.60M |
| Net income | 124.41M | 110.43M | -64.56M | 154.23M | 250.16M |
| Change in cash | - | - | -134.19M | -51.58M | 301.02M |
| Total cash from operating activities | - | - | -144.23M | 384.89M | 459.98M |
| Depreciation | - | - | 135.58M | 143.68M | 118.76M |
| Other cashflows from investing activities | - | - | - | -0.00M | -0.00M |
| Dividends paid | - | - | 3.68M | 4.05M | 5.45M |
| Change to inventory | - | - | -81.78M | 14.39M | -161.99M |
| Change to account receivables | - | - | -74.69M | 122.30M | -95.39M |
| Sale purchase of stock | - | - | - | - | 71.72M |
| Other cashflows from financing activities | - | - | 36.50M | -262.92M | -9.74M |
| Change to netincome | - | - | -73.76M | 44.08M | 127.42M |
| Capital expenditures | 0.00M | 0.00M | 79.71M | 101.23M | 110.02M |
| Change in working capital | - | - | - | - | -148.90M |
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| 0R15 SoftBank Group Corp. |
248.00 5.84% |
4494.00 | - | - | - | - |
| 0R1E Nintendo Co. Ltd. |
-115.00 1.34% |
8476.00 | - | - | - | - |
| 0LC3 Synchrony Financial |
2.34 3.20% |
75.60 | 0.09 | - | 4.97 | - |
| 0HQP CBRE Group Inc. Cl A |
0.15 0.12% |
122.47 | 0.25 | - | 1.18 | - |
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. In addition, it offers patient monitoring systems; anaesthesia machines; medical ventilators and lung monitoring; neonatal incubators and thermoregulation; phototherapy lights and bilirubinometers; surgical and examination lights; medical pendants and infrastructure design; medical gas pipeline system in hospitals; and hospital consumables and accessories, as well as hospital planning and design services. Further, the company offers alcohol and drug testing; diving equipment; fixed gas detectors; hazmat suits; portable gas detection; head and eye protection; rescue and escape; respiratory protection; safety-training systems; thermal imaging cameras; and workshop solution and breathing gas supply, as well as provides various training and services. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh.
| Name | Title | Year Born |
|---|---|---|
| Mr. Stefan A. Drager B.A. | Chairman of the Exec. Board - Drägerwerk Verwaltungs AG | 1963 |
| Mr. Gert-Hartwig Lescow | CFO, Exec. Board Member for IT & Vice Chairman of Exec. Board - Drägerwerk Verwaltungs AG | 1967 |
| Mr. Anton Schrofner | Exec. Board Member for Medical Division - Drägerwerk Verwaltungs AG | 1963 |
| Mr. Rainer Klug | Exec. Board Member for Safety Division - Drägerwerk Verwaltungs AG | 1968 |
| Dr. Reiner Piske | Exec. Board Member for Sales & HR - Drägerwerk Verwaltungs AG | 1970 |
| Stephan Kruse | Pres Bus. Unit Therapy, Medical Div. & Member of Supervisory Board | 1970 |
| Thomas Fischler | Head of Treasury & Investor Relations | NA |
| Mr. Welf Böttcher | Head of Corp. Communications | NA |
| Mr. Stefan A. Drager B.A. | Chairman of the Executive Board - Drägerwerk Verwaltungs AG | 1963 |
| Mr. Gert-Hartwig Lescow | CFO, Executive Board Member for IT & Vice Chairman of Executive Board - Drägerwerk Verwaltungs AG | 1967 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.